Leerink Partners Downgrades Reneo Pharmaceuticals (RPHM) to Market Perform

December 15, 2023 2:00 AM EST Send to a Friend
Leerink Partners analyst Joseph P. Schwartz downgraded Reneo Pharmaceuticals (NASDAQ: RPHM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login